Circulating Cysteine Rich Protein 61 (Cyr61, CCN1) in Chinese Adults: Distribution and Reference Intervals

被引:0
|
作者
Li, Haichuan [1 ,5 ]
Zhang, Yan [2 ]
Qiu, Zhaohui [3 ]
Li, Huidan [1 ]
Zhuang, Wenfang [3 ]
Huo, Rongfen [1 ]
Lin, Jinpiao [4 ]
Ou, Qishui [4 ]
Shen, Baihua [1 ]
Zhai, Tianhang [1 ]
Zhang, Jie [3 ]
Yu, Jing [4 ]
Sheng, Huiming [3 ]
Li, Ningli [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Inst Med Sci, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China
[2] DiaSys Diagnost Syst Shanghai Co Ltd, Shanghai R&D Ctr, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Tong Ren Hosp, Sch Med, 1111 Xianxia Rd, Shanghai 200336, Peoples R China
[4] Fujian Med Univ, Dept Lab Med, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China
[5] Shanghai Chang Ning Matern & Infant Hlth Care Hos, Shanghai, Peoples R China
基金
中国国家自然科学基金; 上海市自然科学基金;
关键词
serum Cyr61 level; reference intervals; gender; age; PROTECTIVE ROLE; EXPRESSION; INFLAMMATION; MIGRATION; RECEPTORS; DISEASE; FAMILY;
D O I
10.7754/Clin.Lab.2020.191210
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The circulating levels of Cyr61 (also known as CCN1) may prove to have great clinical value in the diagnosis, monitoring and prognosis of many disorders in humans. However, the reference intervals (RIs) for this analyte in human subjects have not previously been well established. Therefore, establishing RIs and determining the distribution of circulating Cyr61 levels are very important for future clinical studies and could provide an orientation value for exploring its clinical usefulness. Methods: The Cyr61 levels in 2,514 healthy Chinese Han subjects (1,250 males and 1,264 females, aged 18 - 88 years, recruited from 4 hospitals in Shanghai and Fujian) were measured with a sandwich ELISA (R&D Systems, USA). The RIs were determined in a manner consistent with the Clinical and Laboratory Standards Institute guidelines. Results: The levels of serum Cyr61 showed a non-Gaussian distribution. A statistically significant difference was observed between the males and females such that the median level of Cyr61 in the males was significantly higher than that in the females. Furthermore, the Cyr61 levels significantly increased with age in the female group whereas no difference was observed among the different age groups among the males. The RIs for serum Cyr61 were 3.3 - 184 pg/mL and 5.0 - 182 pg/mL in females aged 18 - 45 and 46 - 88 years, respectively. The RI for serum Cyr61 was 4.0 - 198 pg/mL in the males. Conclusions: The RIs for serum Cyr61 were established among Chinese Han individuals. The effects of age and gender on the distribution characteristics of serum Cyr61 were studied, revealing that the RIs were gender and, in females, age-specific, which may suggest that a female hormone, estrogen plays a role in the regulation of Cyr61 expression in vivo.
引用
收藏
页码:674 / 680
页数:7
相关论文
共 50 条
  • [21] CYR61 (CCN1) is essential for placental development and vascular integrity
    Mo, FE
    Muntean, AG
    Chen, CC
    Stolz, DB
    Watkins, SC
    Lau, LF
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (24) : 8709 - 8720
  • [22] CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma
    Wei, Jing
    Yu, Guanzhen
    Shao, Genbao
    Sun, Aiqin
    Chen, Miao
    Yang, Wannian
    Lin, Qiong
    ONCOTARGET, 2016, 7 (21) : 31067 - 31078
  • [23] Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking
    Yalin Emre
    Beat A Imhof
    Seminars in Immunopathology, 2014, 36 : 253 - 259
  • [24] Hypoxia-induced changes in Cyr61 (CCN1) -: Alternative splicing
    Hirschfeld, M.
    Jaeger, M.
    Stickeler, E.
    ONKOLOGIE, 2008, 31 : 31 - 31
  • [25] CYR61 (CCN1) is essential for placental development and vascular integrity.
    Mo, FE
    Chen, CC
    Muntean, AG
    Stolz, DB
    Watkins, SC
    Lau, LF
    BLOOD, 2002, 100 (11) : 124A - 124A
  • [26] Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney
    Sawai, Kazutomo
    Mukoyama, Masashi
    Mori, Kiyoshi
    Kasahara, Masato
    Koshikawa, Masao
    Yokoi, Hideki
    Yoshioka, Tetsuro
    Ogawa, Yoshihisa
    Sugawara, Akira
    Nishiyama, Hiroyuki
    Yamada, Shigehito
    Kuwahara, Takashi
    Saleem, Moin A.
    Shiota, Kohei
    Ogawa, Osamu
    Miyazato, Mikiya
    Kangawa, Kenji
    Nakao, Kazuwa
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 293 (04) : F1363 - F1372
  • [27] When Breast Cancer Wants to Spread, Suppress CYR61/CCN1
    Hellinger, Johanna
    Silke, Huechel
    Goetz, Lena
    Bauerschmitz, Gerd
    Emons, Guenter
    Gruendker, Carsten
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 13 - 13
  • [28] CYR61/CCN1: A Novel Mediator of Epidermal Hyperplasia and Inflammation in Psoriasis?
    Quan, Taihao
    Johnston, Andrew
    Gudjonsson, Johann E.
    Fisher, Gary J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (11) : 2562 - 2564
  • [29] Functional domains of CCN1 (Cyr61) regulate breast cancer progression
    O'Kelly, James
    Chung, Alice
    Lemp, Nathan
    Chumakova, Katya
    Yin, Dong
    Wang, He-Jing
    Said, Jonathan
    Gui, Dorina
    Miller, Carl W.
    Karlan, Beth Y.
    Koeffler, H. Phillip
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (01) : 59 - 67
  • [30] Regulation of CCN1 (Cyr61) in a porcine model of intestinal ischemia/reperfusion
    Shegarfi, Hamid
    Krohn, Claus Danckert
    Gundersen, Yngvar
    Kjeldsen, Signe Flood
    Hviid, Claus V. B.
    Ruud, Tom Erik
    Aasen, Ansgar O.
    INNATE IMMUNITY, 2015, 21 (05) : 453 - 462